Aemetis, Inc. (NASDAQ:AMTX - Get Free Report) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $2.58 and traded as low as $1.44. Aemetis shares last traded at $1.44, with a volume of 1,296,914 shares trading hands.
Analysts Set New Price Targets
Several research analysts recently commented on the company. HC Wainwright reissued a "buy" rating and set a $28.00 target price on shares of Aemetis in a research note on Friday, March 14th. Ascendiant Capital Markets upped their target price on shares of Aemetis from $18.00 to $19.00 and gave the stock a "buy" rating in a research note on Monday, March 17th. Finally, StockNews.com upgraded shares of Aemetis to a "sell" rating in a report on Wednesday, February 5th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $14.56.
Get Our Latest Analysis on AMTX
Aemetis Trading Up 12.0 %
The firm has a market cap of $79.45 million, a price-to-earnings ratio of -0.66 and a beta of 1.30. The firm's fifty day moving average price is $1.78 and its 200-day moving average price is $2.55.
Institutional Trading of Aemetis
A number of large investors have recently made changes to their positions in the company. ProShare Advisors LLC acquired a new stake in shares of Aemetis in the fourth quarter valued at approximately $27,000. Bank of America Corp DE raised its holdings in shares of Aemetis by 37.8% in the fourth quarter. Bank of America Corp DE now owns 56,675 shares of the specialty chemicals company's stock valued at $152,000 after buying an additional 15,533 shares during the last quarter. Jane Street Group LLC boosted its stake in shares of Aemetis by 1,130.0% during the fourth quarter. Jane Street Group LLC now owns 374,016 shares of the specialty chemicals company's stock worth $1,006,000 after buying an additional 343,609 shares during the period. Northern Trust Corp grew its holdings in shares of Aemetis by 3.7% during the fourth quarter. Northern Trust Corp now owns 297,023 shares of the specialty chemicals company's stock worth $799,000 after buying an additional 10,658 shares during the last quarter. Finally, Susquehanna Fundamental Investments LLC acquired a new position in Aemetis in the 4th quarter valued at about $227,000. 27.02% of the stock is owned by institutional investors and hedge funds.
About Aemetis
(
Get Free Report)
Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.
Featured Articles
Before you consider Aemetis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aemetis wasn't on the list.
While Aemetis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
